Platinum based anticancer drugs in clinical trials have serious side effects.
Anticancer drug screening is most attractive field due to increasing cancer threats.
Metal complexes show mechanism of action different from that of cisplatin.
Design of agents targeting DNA and mitochondria is important in medicinal chemistry.